Wednesday, November 24, 2021 7:41:20 AM
Literature Database
Successful treatment of severe lamotrigine intoxication with CytoSorb hemoadsorption
Caterina Reuchsel, Falk A. Gonnert | Department of Anesthesiology and Intensive Care Medicine, SRH Klinikum Gera, Germany | Blood Purif 2021: epub
11/24/2021
New!Peer Reviewed Published DataSafetyCase of the weekCase reportCritical CareCRRT (pre or post filter)Drug removalIntoxication
Download documentDownload documentLink to source
Summary
CoW 47/2021 – A 60-year-old female was admitted to the Emergency Department after she was found unconscious by her husband.
Case presentation
Neither naloxone nor glucose improved the patient’s vigilance and no causative pathology was found on the CT scan
The patient was intubated and ventilated while already in a deep coma and was transferred to the intensive care unit (ICU)
Intoxication with the anti-epileptic lamotrigine was suspected, so a lipid infusion was administered in consultation with the Poison Control Centre
Electroencephalography (EEG) showed no seizure potentials, while laboratory analysis confirmed significantly elevated lamotrigine plasma levels that were not being reduced by conventional therapeutic measures, and did also not decline over the following days
To try removal from the blood, treatment with CytoSorb hemoadsorption cartridge was finally started on day 8 together with continuous renal replacement therapy (CRRT)
Treatment
In total, 3 hemoadsorbers were used for 44 consecutive hours
CytoSorb was used in combination with CRRT run in veno-venous hemodialysis (CVVHD) mode
Blood flow rate: 150 ml/min
Measurements
Neurologic status
Lamotrigine levels
Overall clinical condition
Results
Despite having been deeply comatose for days before, the patient tried to open her eyes upon request within the first 24 hours of ongoing extracorporeal therapy
This was accompanied by a rapid and sustained decrease in lamotrigine plasma concentrations
Furthermore, a clinical improvement (vigilance) was noticed during and after the treatment
Patient Follow-up
Following cessation of combined CRRT and CytoSorb therapy, the EEG showed intermittent epileptic activity and levetiracetam was started
By the following day, the seizure potentials were no longer detectable under therapy
The patient was clinically awake, could be extubated, and was able to be transferred to the Stroke Unit in a stable condition one day later
Conclusion
To our knowledge, this is the first clinical case describing the successful application of CytoSorb hemoadsorption in a patient with severe lamotrigine intoxication
Comparison of pre and post adsorber levels suggests direct adsorption of the drug by the adsorber
As no antidote exists, hemoadsorption with the CytoSorb device could represent a viable treatment option for patients with severe lamotrigine intoxication.
Recent CTSO News
- CytoSorbents to Present at the H.C. Wainwright 26ᵗʰ Annual Global Investment Conference • GlobeNewswire Inc. • 08/27/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/20/2024 08:51:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/16/2024 10:58:42 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/16/2024 10:57:45 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/16/2024 09:28:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/16/2024 09:12:04 PM
- CytoSorbents Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 08/16/2024 08:05:00 PM
- CytoSorbents Reports Second Quarter 2024 Financial and Operational Results • GlobeNewswire Inc. • 08/13/2024 08:19:55 PM
- CytoSorbents Appoints Peter J. Mariani Chief Financial Officer • GlobeNewswire Inc. • 08/13/2024 08:18:28 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 08:04:32 PM
- CytoSorbents to Report Second Quarter 2024 Operating and Financial Results • GlobeNewswire Inc. • 08/07/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 08:12:56 PM
- CytoSorbents Announces Compliance with Nasdaq Minimum Bid Price Requirement • GlobeNewswire Inc. • 08/01/2024 11:00:00 AM
- CytoSorbents Unveils Newly Redesigned, Unified Company and Product Website • GlobeNewswire Inc. • 07/29/2024 12:00:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 07/26/2024 09:14:03 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/26/2024 09:11:21 PM
- CytoSorbents to Present at the Inaugural American Association of Physicians of Indian Origin (AAPI) World Health Congress • GlobeNewswire Inc. • 07/17/2024 11:00:00 AM
- CytoSorbents Secures $20 Million Credit Facility • GlobeNewswire Inc. • 07/02/2024 11:00:00 AM
- CytoSorbents Announces Regulatory Approval of CytoSorb® in Taiwan • GlobeNewswire Inc. • 06/24/2024 11:00:00 AM
- CytoSorbents Announces the Launch and Immediate Availability of the PuriFi™ Blood Pump in the European Union • GlobeNewswire Inc. • 06/13/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/10/2024 08:31:20 PM
- CytoSorbents to Host its 2024 Virtual Annual Stockholders Meeting • GlobeNewswire Inc. • 06/05/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2024 08:35:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 09:23:00 PM
- CytoSorbents Reports First Quarter 2024 Results • GlobeNewswire Inc. • 05/09/2024 08:17:23 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM